# Peginesatide for Anemia in Chronic Hemodialysis Patients

> **NCT00228449** · PHASE2 · COMPLETED · sponsor: **Affymax** · enrollment: 165 (actual)

## Conditions studied

- Anemia
- Chronic Kidney Disease
- Chronic Renal Failure

## Interventions

- **DRUG:** peginesatide

## Key facts

- **NCT ID:** NCT00228449
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2012-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00228449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00228449, "Peginesatide for Anemia in Chronic Hemodialysis Patients". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT00228449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*